{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:07Z","timestamp":1791223507643,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.04.115","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T12:54:18Z","timestamp":1306068858000},"page":"6371-6378","source":"Crossref","is-referenced-by-count":32,"title":["Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection"],"prefix":"10.1016","volume":"29","author":[{"given":"S.","family":"Barnoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nemelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.L.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.T.","family":"Ranallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (4)","key":"10.1016\/j.vaccine.2011.04.115_bib0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MOG.0b013e32830007f7","article-title":"Host\u2013bacteria homeostasis in the healthy and inflamed gut","volume":"24","author":"Sansonetti","year":"2008","journal-title":"Current Opinion in Gastroenterology"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.115_bib0010","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2011.04.115_bib0015","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/j.vaccine.2005.07.013","article-title":"Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model","volume":"24","author":"Barry","year":"2006","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.115_bib0020","first-page":"540","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nature Reviews"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.04.115_bib0025","first-page":"109","article-title":"Live oral Shigella vaccine: vaccination schedule and the effect of booster dose","volume":"21","author":"Mel","year":"1974","journal-title":"Acta Microbiologica Academiae Scientiarum Hungaricae"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.04.115_bib0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/164.3.533","article-title":"Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei","volume":"164","author":"Formal","year":"1991","journal-title":"Journal of Infectious Diseases"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.04.115_bib0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/IAI.50.3.620-629.1985","article-title":"Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli","volume":"50","author":"Hale","year":"1985","journal-title":"Infection and Immunity"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.04.115_bib0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/14760584.5.5.669","article-title":"Live-attenuated Shigella vaccines","volume":"5","author":"Venkatesan","year":"2006","journal-title":"Expert Review of Vaccines"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.04.115_bib0045","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","article-title":"Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a","volume":"26","author":"Turbyfill","year":"2008","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.115_bib0050","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4049\/jimmunol.120.6.1892","article-title":"The role of Peyer's patches in the local immune response of rabbit ileum to live bacteria","volume":"120","author":"Keren","year":"1978","journal-title":"Journal of Immunology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.115_bib0055","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0264-410X(91)90128-S","article-title":"OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis","volume":"9","author":"Sansonetti","year":"1991","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.115_bib0060","doi-asserted-by":"crossref","first-page":"e4713","DOI":"10.1371\/journal.pone.0004713","article-title":"Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon","volume":"4","author":"Coron","year":"2009","journal-title":"PloS ONE"},{"issue":"August","key":"10.1016\/j.vaccine.2011.04.115_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1196\/annals.1326.025","article-title":"The bacterial weaponry: lessons from Shigella","volume":"1072","author":"Sansonetti","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.04.115_bib0070","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1128\/jb.175.8.2189-2196.1993","article-title":"Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement","volume":"175","author":"Goldberg","year":"1993","journal-title":"Journal of Bacteriology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.04.115_bib0075","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/IAI.69.10.5959-5966.2001","article-title":"Molecular basis of the intracellular spreading of Shigella","volume":"69","author":"Suzuki","year":"2001","journal-title":"Infection and Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.115_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1462-5822.2005.00652.x","article-title":"Intracellular survival of Shigella","volume":"8","author":"Ogawa","year":"2006","journal-title":"Cellular Microbiology"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.04.115_bib0085","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0092-8674(94)90358-1","article-title":"Cadherin expression is required for the spread of Shigella flexneri between epithelial cells","volume":"76","author":"Sansonetti","year":"1994","journal-title":"Cell"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.04.115_bib0090","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1365-2958.1992.tb00885.x","article-title":"IcsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread","volume":"6","author":"Allaoui","year":"1992","journal-title":"Molecular Microbiology"},{"issue":"May (4)","key":"10.1016\/j.vaccine.2011.04.115_bib0095","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2958.2003.03489.x","article-title":"IcsB, secreted via the type III secretion system, is chaperoned by IpgA and required at the post-invasion stage of Shigella pathogenicity","volume":"48","author":"Ogawa","year":"2003","journal-title":"Molecular Microbiology"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.04.115_bib0100","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1073\/pnas.86.10.3867","article-title":"Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin","volume":"86","author":"Bernardini","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.04.115_bib0105","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1046\/j.1365-2958.1997.2871652.x","article-title":"SopA, the outer membrane protease responsible for polar localization of IcsA in Shigella flexneri","volume":"23","author":"Egile","year":"1997","journal-title":"Molecular Microbiology"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.04.115_bib0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JB.186.3.699-705.2004","article-title":"Regulation of IcsP, the outer membrane protease of the Shigella actin tail assembly protein IcsA, by virulence plasmid regulators VirF and VirB","volume":"186","author":"Wing","year":"2004","journal-title":"Journal of Bacteriology"},{"issue":"September\u2013October (7\u20138)","key":"10.1016\/j.vaccine.2011.04.115_bib0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0923-2508(90)90129-E","article-title":"Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1","volume":"141","author":"Fontaine","year":"1990","journal-title":"Research in Microbiology"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.04.115_bib0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2958.1999.01356.x","article-title":"The unipolar Shigella surface protein IcsA is targeted directly to the bacterial old pole: IcsP cleavage of IcsA occurs over the entire bacterial surface","volume":"32","author":"Steinhauer","year":"1999","journal-title":"Molecular Microbiology"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2011.04.115_bib0125","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0264-410X(96)00002-3","article-title":"Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains","volume":"14","author":"Alexander","year":"1996","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.115_bib0130","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.66.9.4572-4576.1998","article-title":"Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model","volume":"66","author":"Hartman","year":"1998","journal-title":"Infection and Immunity"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.115_bib0135","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","article-title":"Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine","volume":"70","author":"Venkatesan","year":"2002","journal-title":"Infection and Immunity"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.04.115_bib0140","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.vaccine.2006.11.067","article-title":"Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain","volume":"25","author":"Ranallo","year":"2007","journal-title":"Vaccine"},{"issue":"February (Number 1)","key":"10.1016\/j.vaccine.2011.04.115_bib0145","first-page":"88","article-title":"Safety and colonization of two novel virG(icsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)","volume":"58","author":"Collins","year":"2008","journal-title":"Comparative Medicine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.115_bib0150","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infection and Immunity"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.115_bib0155","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infection and Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.115_bib0160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infection and Immunity"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.115_bib0165","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infection and Immunity"},{"issue":"June (26)","key":"10.1016\/j.vaccine.2011.04.115_bib0170","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.vaccine.2008.03.079","article-title":"Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate","volume":"26","author":"McKenzie","year":"2008","journal-title":"Vaccine"},{"issue":"6:","key":"10.1016\/j.vaccine.2011.04.115_bib0295","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.vaccine.2009.11.001","article-title":"Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity","volume":"28","author":"Barnoy","year":"2010","journal-title":"Vaccine Feb 10"},{"issue":"September\u2013October (2)","key":"10.1016\/j.vaccine.2011.04.115_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/infdis\/83.2.147","article-title":"Enteric infections in chimpanzees and spider monkeys with special reference to a sulfadiazine resistant Shigella","volume":"83","author":"Galton","year":"1948","journal-title":"Journal of Infectious Diseases"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.04.115_bib0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1574-6968.1991.tb04210.x","article-title":"Potentials of Shigella flexneri Y strain TSF21 as a candidate vaccine against shigellosis: safety, immunogenicity and protective efficacy in Bonnet monkeys","volume":"3","author":"Ashraf","year":"1991","journal-title":"FEMS Microbiology Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2011.04.115_bib0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0264-410X(93)90358-5","article-title":"AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys","volume":"11","author":"Karnell","year":"1993","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.115_bib0195","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1128\/IAI.60.6.2218-2224.1992","article-title":"Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen","volume":"60","author":"Kotloff","year":"1992","journal-title":"Infection and Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.115_bib0300","first-page":"54","article-title":"A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis)","volume":"60","author":"Shipley","year":"2010","journal-title":"Comp Med"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2011.04.115_bib0205","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.vaccine.2005.11.040","article-title":"Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine","volume":"24","author":"Oaks","year":"2006","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.115_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp","volume":"53","author":"Oaks","year":"1986","journal-title":"Infection and Immunity"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.115_bib0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(95)80006-Y","article-title":"Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates","volume":"13","author":"Baqar","year":"1995","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.115_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4269\/ajtmh.1995.53.47","article-title":"Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances","volume":"53","author":"Munoz","year":"1995","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.04.115_bib0225","first-page":"363","article-title":"Immune response to and histopathology of Campylobacter jejuni infection in ferrets (Mustela putorius furo)","volume":"59","author":"Nemelka","year":"2009","journal-title":"Comparative Medicine"},{"issue":"37:","key":"10.1016\/j.vaccine.2011.04.115_bib0305","first-page":"6076","article-title":"Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers","volume":"28","author":"Tribble","year":"2010","journal-title":"Vaccine Aug 23"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.115_bib0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0016-5085(75)80008-4","article-title":"Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies","volume":"68","author":"Rout","year":"1975","journal-title":"Gastroenterology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.115_bib0240","first-page":"503","article-title":"Exerimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri. An electron microscope study","volume":"52","author":"Takeuchi","year":"1968","journal-title":"American Journal of Pathology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.115_bib0245","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/JB.91.6.2368-2376.1966","article-title":"Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri","volume":"91","author":"Formal","year":"1966","journal-title":"Journal of Bacteriology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.115_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1699-0463.1990.tb01038.x","article-title":"The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions","volume":"98","author":"Katakura","year":"1990","journal-title":"Apmis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.115_bib0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0264-410X(92)90069-V","article-title":"Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies","volume":"10","author":"Karnell","year":"1992","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.115_bib0260","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.59.7.2341-2350.1991","article-title":"Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides","volume":"59","author":"Oberhelman","year":"1991","journal-title":"Infection and Immunity"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.115_bib0265","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/IAI.61.9.3825-3831.1993","article-title":"Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection","volume":"61","author":"Barzu","year":"1993","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2011.04.115_bib0310","unstructured":"Venkatesan M, Kaminski RW, Ranallo RT. Shigellosis. Elsevier Inc. Chapter 58: Shigellosis in \u201cVaccines for Biodefense and Emerging Infectious Diseases\u201d 2008. Elsevier, Ltd. Ed. LR Stanberry & Alan DT Barrett, Chapter 58:pg 1153-1181."},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.115_bib0275","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/IAI.56.11.2933-2941.1988","article-title":"Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies","volume":"56","author":"Mills","year":"1988","journal-title":"Infection and Immunity"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2011.04.115_bib0280","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.0610833104","article-title":"O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative","volume":"104","author":"Chowers","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.115_bib0285","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Review of Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.115_bib0290","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/00365549309008545","article-title":"Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients","volume":"25","author":"Li","year":"1993","journal-title":"Scandinavian Journal of Infectious Diseases"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:32:42Z","timestamp":1686079962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":58,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11006815"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.115","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}